Clinical Trials

Merck and Pfizer have announced that the phase III JAVELIN Gastric 300 trial did not meet its primary endpoint of...

Nippon Chemiphar has announced that the phase-1 clinical trial of NC-2500, a novel xanthine oxidoreductase (XOR) inhibitor, was completed, indicating...

Amgen announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study...

Takeda Pharmaceutical Company Limited announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a...

Merck KGaA, Darmstadt, Germany, and Pfizer Inc announced that the Phase III JAVELIN Gastric 300 trial did not meet its...

Exelixis has announced that the phase 3 CELESTIAL trial results have been accepted as a late-breaking presentation at the 2018...

BiondVax Pharmaceuticals Ltd. has announced the signing of the clinical trial agreement (CTA) for a phase 2 clinical trial with...

Roche has announced that the phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that...

Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study...

Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of...